Common Contracts
3 similar Securities Purchase Agreement contracts by HedgePath Pharmaceuticals, Inc.
SECURITIES PURCHASE AGREEMENT Dated January 8, 2018 by and between HEDGEPATH PHARMACEUTICALS, INC. and MAYNE PHARMA VENTURES PTY LTDSecurities Purchase Agreement • January 11th, 2018 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into this 8th day of January, 2018 (the “Signing Date”), by and between MAYNE PHARMA VENTURES PTY LTD, an Australian company ACN 168 896 357 (“Mayne Pharma”) and HEDGEPATH PHARMACEUTICALS, INC., a Delaware corporation (“HPPI”).
SECURITIES PURCHASE AGREEMENT Dated May 15, 2015 by and between HEDGEPATH PHARMACEUTICALS, INC. and MAYNE PHARMA VENTURES PTY LTDSecurities Purchase Agreement • August 14th, 2015 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into this 15th day of May, 2015 (the “Signing Date”), by and between MAYNE PHARMA VENTURES PTY LTD, an Australian company ACN 168 896 357 (“Mayne Pharma”) and HEDGEPATH PHARMACEUTICALS, INC., a Delaware corporation (“HPPI”).
SECURITIES PURCHASE AGREEMENT Dated June 24, 2014 by and between HEDGEPATH PHARMACEUTICALS, INC. and MAYNE PHARMA VENTURES PTY LTDSecurities Purchase Agreement • June 30th, 2014 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into this 24th day of June, 2014 (the “Signing Date”), by and between MAYNE PHARMA VENTURES PTY LTD, an Australian company ACN 168 896 357 (“Mayne Pharma”) and HEDGEPATH PHARMACEUTICALS, INC., a Delaware corporation (“HPPI”).
